Reduced Physician Claims for Otitis Media After Implementation of Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  2009-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/INF.0b013e3181bad212PMID 19710582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National, state, and local area vaccination coverage among children aged 19-35 months --- United States, 2009.

  2010cited by this paper
• How to compare the efficacy of conjugate vaccines to prevent acute otitis media?

  2009cited by this paper
• Clinical qualitative evaluation of the diagnosis of acute otitis media in general practice.

  2008cited by this paper
• Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997–2004

  2008cited by this paper
• Brief review of the clinical effectiveness of PREVENAR against otitis media.

  2007cited by this paper
• Effectiveness of seven-valent pneumococcal conjugate vaccine.

  2007cited by this paper
• Immunogenicity and Boosting After a Reduced Number of Doses of a Pneumococcal Conjugate Vaccine in Infants and Toddlers

  2006cited by this paper
• Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.

  2006cited by this paper
• Forecasting with Unobserved Components Time Series Models

  2006cited by this paper
• National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States

  2006cited by this paper
• Diagnosis and management of acute otitis media.

  2004cited by this paper
• Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children

  2004cited by this paper
• Treatment of Acute Otitis Media Consensus Recommendations

  2002influential reference
• Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

  2001cited by this paper
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

  2000cited by this paper
• Structural time series models in medicine

  1996cited by this paper
• Stamp 5.0 : structural time series analyser, modeller and predictor

  1996cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• Testing for serial correlation in least squares regression. II.

  1950cited by this paper
• Testing for serial correlation in least squares regression. I.

  1950cited by this paper

• Otoscopy-based diagnosis of paediatric acute otitis media: An evaluation of guideline adherence

  2025cites this paper
• Protection Against Persistent HPV-16/18 Infection After Different Number of Doses of Quadrivalent Vaccine in Girls and Young Women

  2025cites this paper
• Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review.

  2022cites this paper
• Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

  2021cites this paper
• Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada.

  2021cites this paper
• Health and Economic Impact of Routine Pediatric Pneumococcal Immunization Programs in Canada: A Retrospective Analysis

  2020cites this paper
• Burden of respiratory infections and otitis media in the Inuit population of Nunavik, Quebec, Canada

  2020cites this paper
• Awareness and attitudes of Saudi parents toward otitis media in children

  2020cites this paper
• Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey

  2019cites this paper
• Bacteriological profiles of acute suppurative otitis media in children in Brazzaville, Congo

  2019cites this paper
• 29 – Otitis Media

  2018cites this paper
• Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada

  2018cites this paper
• 46 – Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines

  2018cites this paper
• Whole-genome Based Investigation of Streptococcus pneumoniae Infections

  2017cites this paper
• The Association between Birth by Caesarean Section and Otitis Media in Nova Scotian Children

  2017cites this paper
• Exploring the acceptability of the available pneumococcal conjugate vaccines in Canadian health care professionals and immunization experts.

  2017cites this paper
• Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate Vaccines

  2017cites this paper
• Pneumococcal Phenotype and Interaction with Nontypeable Haemophilus influenzae as Determinants of Otitis Media Progression

  2017cites this paper
• Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil

  2017cites this paper
• Title: Pneumococcal phenotype and interaction with nontypeable Haemophilus influenzae as determinants of otitis media progression Running title: Otitis media progression by S. pneumoniae and NTHi

  2017cites this paper
• Otitis media

  2017cites this paper
• Title: Impact of pneumococcal conjugate vaccines on childhood otitis media in the 1 United Kingdom 2

  2017cites this paper
• Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease.

  2016cites this paper
• Pneumococcal conjugate vaccines for preventing otitis media.

  2016cites this paper
• Management of acute otitis media in children six months of age and older.

  2016cites this paper
• Otitis media

  2016cites this paper
• La prise en charge de l’otite moyenne aiguë chez les enfants de six mois et plus

  2016cites this paper
• Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.

  2015cites this paper
• Impact of Pneumococcal Conjugate Vaccine on Pediatric Tympanostomy Tube Insertion in Partial Immunized Population

  2015cites this paper
• Acute otitis media in young children : randomized controlled trials of antimicrobial treatment, prevention and quality of life

  2015cites this paper
• Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination

  2014cites this paper
• Impact of Pneumococcal Conjugate Vaccines on Microbial Epidemiology and Clinical Outcomes of Acute Otitis Media

  2014cites this paper
• Streptococcus pneumoniae infection: a Canadian

  2013cites this paper
• Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine

  2013cites this paper
• Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule.

  2013cites this paper
• Respiratory infection and otitis media visits in relation to pneumococcal conjugate vaccine use in Saskatchewan.

  2013cites this paper
• Panel 6: Vaccines

  2013cites this paper
• 25 – Pneumococcal conjugate vaccine and pneumococcal common protein vaccines

  2013cites this paper
• Panel 1

  2013cites this paper
• Panel 6

  2013cites this paper
• Streptococcus pneumoniae infection: a Canadian perspective

  2013cites this paper
• Tympanostomy With and Without Adenoidectomy for the Prevention of Recurrences of Acute Otitis Media: A Randomized Controlled Trial

  2012cites this paper
• Prevention of Acute Otitis Media Using Available Vaccines (printer-friendly)

  2012cites this paper
• ワクチンで予防できる病気 (VPD) の現状 —耳鼻科領域におけるワクチンを中心に—

  2012cites this paper
• [Current status of preventing disease with vaccine].

  2012cites this paper
• Prevention of acute otitis media using currently available vaccines.

  2012cites this paper
• The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine

  2012cites this paper
• Letter to the Editor Pneumococcal Conjugate Vaccines and Otitis Media

  2012cites this paper
• Pneumococcal Conjugate Vaccines and Otitis Media

  2012cites this paper
• Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

  2012cites this paper
• Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review

  2012influential citation
• Decline in Early Childhood Respiratory Tract Infections in the Norwegian Mother and Child Cohort Study After Introduction of Pneumococcal Conjugate Vaccination

  2012cites this paper
• 7-Valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary series.

  2012cites this paper
• Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines.

  2012cites this paper
• The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

  2012influential citation
• A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

  2011cites this paper
• Burden of acute otitis media on Canadian families.

  2011cites this paper
• Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination

  2011cites this paper
• 13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge model

  2011cites this paper
• Impact of Universal Pneumococcal Vaccination on Hospitalizations for Pneumonia and Meningitis in Children in Montevideo, Uruguay

  2011cites this paper
• Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience.

  2011cites this paper
• Pneumococcal polysaccharide–protein (CRM197) conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule

  2011cites this paper
• Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience

  2011cites this paper
• Update on acute otitis media in children younger than 2 years of age.

  2011cites this paper
• Markers for bacterial infection in children with fever without source

  2011cites this paper
• Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.

  2011cites this paper
• Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections

  2011cites this paper
• Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

  2011cites this paper
• Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae-associated disease following vaccination with PCV-7: a multicountry analysis.

  2010cites this paper
• Otitis media and its consequences: beyond the earache.

  2010cites this paper
• Évaluation coût-efficacité du programme québécois de vaccination contre le pneumocoque avec un nombre réduit de doses

  2009cites this paper
• Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.

  2009cites this paper
• 27th Annual Meeting of the European Society for Pediatric Infectious Disease

  2009cites this paper
• Infection and Drug Resistance Dovepress Update on Otitis Media – Prevention and Treatment

  year unknowncites this paper